The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network – ADDENDUM

Weiner-Lastinger, Lindsey M; Pattabiraman, Vaishnavi; Konnor, Rebecca; Patel, Prachi; Wong, Emily Y.; Xu, Sunny Y.; Smith, Brian K.; Edwards, Jonathan R.; Dudeck, Margaret A.

doi:10.1017/ice.2022.10

Cited by 8 publications

(6 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9 Clostridium difficile and methicillin-resistant Staphylococcus aureus infections were also reported to have increased in 2020. 10 These increased HAI rates are likely due in part to exhausted workers or lack of sufficient staff, increased acuity of patients who postponed healthcare services early in the pandemic, longer lengths of stay and medical device use, and crisis PPE protocols 10 , 11 , but a shift in focus from routine IPC to pandemic response may have also contributed. Returning to teaching and enforcement of routine IPC practices should aid in reversing these HAI trends.…”

Section: Discussionmentioning

confidence: 99%

Impacts of the COVID-19 pandemic on the infection prevention and control field: Findings from focus groups conducted with association for professionals in infection control & epidemiology (APIC) members in fall 2021

Rebmann

Holdsworth

Lugo

et al. 2023

American Journal of Infection Control

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Impacts of the COVID-19 pandemic on the infection prevention and control field: Findings from focus groups conducted with association for professionals in infection control & epidemiology (APIC) members in fall 2021

Rebmann

Holdsworth

Lugo

et al. 2023

American Journal of Infection Control

View full text Add to dashboard Cite

“…This paper is a review of different retrospective studies, and thus, generalization of the impact of prevention bundles is difficult due to missing data since, generally, most papers were not studying prevention bundles and a few studies correlated bundle implementation with VAP rates. Another limitation of the current review is that all of the included studies were conducted before the onset of the coronavirus disease 2019 (COVID-19) pandemic and, therefore, do not take into consideration the likely increases in VAP rates [ 44 ].…”

Section: Discussionmentioning

confidence: 99%

Narrative Review of the Epidemiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Gulf Cooperation Council Countries

Abdalla¹,

Albarrak

Alhasawi

et al. 2023

Infect Dis Ther

View full text Add to dashboard Cite

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are the most common healthcare-associated infections, with rates varying between countries. Antimicrobial resistance (AMR) among common HAP/VAP pathogens has been reported, and multidrug resistance (MDR) is of further concern across Middle Eastern countries. This narrative review summarizes the incidence and pathogens associated with HAP/VAP in hospitals across Gulf Cooperation Council (GCC) countries. A PubMed literature search was limited to available data on HAP or VAP in patients of any age published within the past 10 years. Reviews, non-English language articles, and studies not reporting HAP/VAP data specific to a GCC country were excluded. Overall, 41 articles, a majority of which focused on VAP, were selected for inclusion after full-text screening. Studies conducted over multiple years showed a general reduction in VAP rates over time, with Gram-negative bacteria the most commonly reported pathogens. Gram-negative isolates reported across GCC countries included Acinetobacter baumannii , Pseudomonas aeruginosa , and Klebsiella pneumoniae . Rates of AMR varied widely among studies, and MDR among A. baumannii , K. pneumoniae , Escherichia coli , P. aeruginosa , and Staphylococcus aureus isolates was commonly reported. In Saudi Arabia, between 2015 and 2019, rates of carbapenem resistance among Gram-negative bacteria were 19–25%; another study (2004–2009) reported antimicrobial resistance rates in Acinetobacter species (60–89%), P. aeruginosa (13–31%), and Klebsiella species (100% ampicillin, 0–13% other antimicrobials). Although limited genotype data were reported, OXA-48 was found in ≥ 68% of patients in Saudi Arabia with carbapenem-resistant Enterobacteriaceae infections. Ventilator utilization ratios varied across studies, with rates up to 0.9 reported in patients admitted to adult medical/surgical intensive care units in both Kuwait and Saudi Arabia. VAP remains a burden across GCC countries albeit with decreases in rates over time. Evaluation of prevention and treatment measures and implementation of a surveillance program could be useful for the management of HAP and VAP.

show abstract

“… 56 Based on a 2020 review of the current evidence, the CDC continues to recommend the use of contact precautions for MRSA colonized or infected patients 67 During the COVID-19 pandemic, hospital-onset MRSA bloodstream infections increased nationally; however, whether declining use of contact precautions for MRSA-colonized or MRSA-infected patients played a significant role in this increase remains unknown. 68 Studies have suggested that patients may be persistent MRSA carriers for prolonged periods (median duration in one study, 8.5 months). 69 , 70 Use of contact precautions for patients with a history of MRSA is recommended.…”

Section: Section 4: Recommended Strategies To Prevent Mrsamentioning

confidence: 96%

SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update

Popovich¹,

Aureden

Ham

et al. 2023

Infect. Control Hosp. Epidemiol.

View full text Add to dashboard Cite

Previously published guidelines have provided comprehensive recommendations for detecting and preventing healthcare-associated infections (HAIs). The intent of this document is to highlight practical recommendations in a concise format designed to assist acute-care hospitals in implementing and prioritizing efforts to prevent methicillin-resistant Staphylococcus aureus (MRSA) transmission and infection. This document updates the “Strategies to Prevent Methicillin-Resistant Staphylococcus aureus Transmission and Infection in Acute Care Hospitals” published in 2014.1 This expert guidance document is sponsored by the Society for Healthcare Epidemiology of America (SHEA). It is the product of a collaborative effort led by SHEA, the Infectious Diseases Society of America (IDSA), the Association for Professionals in Infection Control and Epidemiology (APIC), the American Hospital Association (AHA), and The Joint Commission, with major contributions from representatives of a number of organizations and societies with content expertise.

show abstract

The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the National Healthcare Safety Network – ADDENDUM

Cited by 8 publications

References 1 publication

Impacts of the COVID-19 pandemic on the infection prevention and control field: Findings from focus groups conducted with association for professionals in infection control & epidemiology (APIC) members in fall 2021

Impacts of the COVID-19 pandemic on the infection prevention and control field: Findings from focus groups conducted with association for professionals in infection control & epidemiology (APIC) members in fall 2021

Narrative Review of the Epidemiology of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia in Gulf Cooperation Council Countries

SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute-care hospitals: 2022 Update

Contact Info

Product

Resources

About